Journal of Clinical Endocrinology and Metabolism (JCEM)
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome
2013
-
Medical Management of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop
2009
-
Quantification of the Soluble Leptin Receptor in Human Blood by Ligand-Mediated Immunofunctional Assay
2002
-
Contemporary Clinical Perspectives on Targeting Remission of Type 2 Diabetes.
109:1179-1188.
2024
-
Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults.
109:680-690.
2024
-
Vertebral Body Reshaping after Fractures: An Important Index of Recovery in Glucocorticoid-Treated Children.
109:e1225-e1237.
2024
-
Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy.
109:536-548.
2024
-
Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline.
108:529-562.
2023
-
Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study.
108:563-584.
2023
-
Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.
108:507-528.
2023
-
Screening Accuracy of the 50 g-Glucose Challenge Test in Twin Compared With Singleton Pregnancies.
107:2854-2864.
2022
-
Enhancing the Trustworthiness of the Endocrine Society’s Clinical Practice Guidelines.
107:2129-2138.
2022
-
Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.
107:2101-2128.
2022
-
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
107:e3448-e3454.
2022
-
Gastrointestinal Symptoms in Type 1 Diabetes: Relationship With Autoimmune and Microvascular Complications.
107:e2431-e2437.
2022
-
Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”.
107:e2651-e2652.
2022
-
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
107:1441-1460.
2022
-
Transient vs Permanent Congenital Hypothyroidism in Ontario, Canada: Predictive Factors and Scoring System.
107:638-648.
2022
-
Vitamin D Supplementation and Fractures in Adults: A Systematic Umbrella Review of Meta-Analyses of Controlled Trials.
107:882-898.
2022
-
Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE Deficiency.
107:538-548.
2022
-
Myopia and Early-Onset Type 2 Diabetes: A Nationwide Cohort Study.
107:e663-e671.
2022
-
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.
107:1-9.
2022
-
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.
107:e372-e385.
2022
-
Asthma in Youth and Early-onset Type 2 Diabetes: A Nationwide Study of 1.72 Million Israeli Adolescents.
106:e5043-e5053.
2021
-
Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-Treated Rheumatic Disorders.
106:e5195-e5207.
2021
-
Adolescent Thyroid Disorders and Risk for Type 2 Diabetes in Young Adulthood.
106:e3426-e3435.
2021
-
Impaired Function and Altered Morphology in the Skeletal Muscles of Adult Men and Women With Type 1 Diabetes.
106:2405-2422.
2021
-
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial.
106:1345-1351.
2021
-
Impact of a Gluten-Free Diet on Quality of Life and Health Perception in Patients With Type 1 Diabetes and Asymptomatic Celiac Disease.
106:e1984-e1992.
2021
-
14-Day Ketone Supplementation Lowers Glucose and Improves Vascular Function in Obesity: A Randomized Crossover Trial.
106:1738-1754.
2021
-
Stuttering and Incident Type 2 Diabetes: A Population-Based Study of 2.2 Million Adolescents.
106:e978-e987.
2021
-
The Relationship Between Glucose Control and Cognitive Function in People With Diabetes After a Lacunar Stroke.
106:1521-1528.
2021
-
Diabetes, Brain Infarcts, Cognition, and Small Vessels in the Canadian Alliance for Healthy Hearts and Minds Study.
106:e891-e898.
2021
-
Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood.
106:e34-e44.
2021
-
Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin.
105:2532-2540.
2020
-
Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia.
104:213-222.
2019
-
The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study.
102:3218-3225.
2017
-
Validation of the ORIGIN Cardiovascular Biomarker Panel and the Value of Adding Troponin I in Dysglycemic People.
102:2251-2257.
2017
-
Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial.
102:1596-1605.
2017
-
Attenuation of Resting but Not Load-Mediated Protein Synthesis in Prostate Cancer Patients on Androgen Deprivation.
102:1076-1083.
2017
-
Attenuation of Resting but Not Load-Mediated Protein Synthesis in Prostate Cancer Patients on Androgen Deprivation.
102:1076-1083.
2017
-
Management of Hypoparathyroidism: Summary Statement and Guidelines.
101:2273-2283.
2016
-
Presentation of Hypoparathyroidism: Etiologies and Clinical Features.
101:2300-2312.
2016
-
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.
101:364-389.
2016
-
Cognitive Performance at Late Adolescence and the Risk for Impaired Fasting Glucose Among Young Adults.
100:4409-4416.
2015
-
Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis.
100:3408-3417.
2015
-
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies.
100:2682-2689.
2015
-
Sex Differences in the Effects of Weight Loss Diets on Bone Mineral Density and Body Composition: POUNDS LOST Trial.
100:2463-2471.
2015
-
Cancer-Related Worry in Canadian Thyroid Cancer Survivors.
100:977-985.
2015
-
The Choice of Normative Pediatric Reference Database Changes Spine Bone Mineral Density Z-Scores But Not the Relationship Between Bone Mineral Density and Prevalent Vertebral Fractures.
100:1018-1027.
2015
-
Medical Management of Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.
99:3607-3618.
2014
-
Effect of Odanacatib on BMD and Fractures: Estimates from Bayesian Univariate and Bivariate Meta-analyses.
99:3070-3079.
2014
-
Efficacy of Vitamin D Supplementation in Depression in Adults: A Systematic Review.
99:757-767.
2014
-
Empirically Based Composite Fracture Prediction Model From the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).
99:817-826.
2014
-
Erratum.
99:1096-1096.
2014
-
Endurance Training Modulates Intramyocellular Lipid Compartmentalization and Morphology in Skeletal Muscle of Lean and Obese Women.
98:4852-4862.
2013
-
The Endocrine Society Guidelines: When the Confidence Cart Goes Before the Evidence Horse.
98:3246-3252.
2013
-
Calcium and Vitamin D Intake and Mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos).
98:3010-3018.
2013
-
Skeletal Muscle Abnormalities in Girls and Adolescents With Turner Syndrome.
98:2521-2527.
2013
-
Two Weeks of Reduced Activity Decreases Leg Lean Mass and Induces “Anabolic Resistance” of Myofibrillar Protein Synthesis in Healthy Elderly.
98:2604-2612.
2013
-
Association of Postburn Fatty Acids and Triglycerides with Clinical Outcome in Severely Burned Children.
98:314-321.
2013
-
Diets Higher in Dairy Foods and Dietary Protein Support Bone Health during Diet- and Exercise-Induced Weight Loss in Overweight and Obese Premenopausal Women.
97:251-260.
2012
-
Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk.
96:1727-1736.
2011
-
Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study.
96:1368-1376.
2011
-
Maternal Fructose Intake during Pregnancy and Lactation Alters Placental Growth and Leads to Sex-Specific Changes in Fetal and Neonatal Endocrine Function.
96:871-871.
2011
-
Association of 25(OH)D and PTH with Metabolic Syndrome and Its Traditional and Nontraditional Components.
96:168-175.
2011
-
Association of Hematological Parameters with Insulin Resistance and beta-Cell Dysfunction in Nondiabetic Subjects (vol 94, pg 3824, 2009).
95:5465-5465.
2010
-
Association of hematological parameters with insulin resistance and β-cell dysfunction in nondiabetic subjects (Journal of Clinical Endocrinology and Metabolism (2009) 94, (3824-3832)).
95:5465.
2010
-
Hyperinsulinemia Precedes Insulin Resistance in Mice Lacking Pancreatic β-Cell Leptin Signaling.
95:4080-4080.
2010
-
Prenatal Determinants of Uterine Volume and Ovarian Reserve in Adolescence.
94:4931-4937.
2009
-
Skeletal Muscle Lipogenic Protein Expression Is Not Different between Lean and Obese Individuals: A Potential Factor in Ceramide Accumulation.
94:5053-5061.
2009
-
Effects of Maternal Dexamethasone Treatment in Early Pregnancy on Pituitary-Adrenal Axis in Fetal Sheep.
94:4625-4625.
2009
-
Association of Hematological Parameters with Insulin Resistance and β-Cell Dysfunction in Nondiabetic Subjects.
94:3824-3832.
2009
-
The Relationship between Maternal and Umbilical Cord Androgen Levels and Polycystic Ovary Syndrome in Adolescence: A Prospective Cohort Study.
94:3714-3720.
2009
-
Abnormal Insulin Sensitivity Persists up to Three Years in Pediatric Patients Post-Burn.
94:1656-1664.
2009
-
Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop.
94:335-339.
2009
-
Surgery for Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop.
94:366-372.
2009
-
The Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism Revisited.
94:333-334.
2009
-
Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate.
93:3785-3793.
2008
-
Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature.
93:3810-3816.
2008
-
Beneficial Effects of Propylthiouracil plusl-Thyroxine Treatment in a Patient with a Mutation inMCT8.
93:2084-2088.
2008
-
Urinary Cortisol and Catecholamine Excretion after Burn Injury in Children.
93:1270-1275.
2008
-
A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System.
93:666-673.
2008
-
Absence of Stabilizing Mutations of β-Catenin Encoded by CTNNB1 Exon 3 in a Large Series of Sporadic Parathyroid Adenomas.
92:1564-1566.
2007
-
Age at Menarche: Influences of Prenatal and Postnatal Growth.
92:46-50.
2007
-
The Suppressor of Cytokine Signaling 3 Inhibits Leptin Activation of AMP-Kinase in Cultured Skeletal Muscle of Obese Humans.
91:3592-3597.
2006
-
Adiponectin, Adiposity, and Insulin Resistance in Children and Adolescents.
91:2119-2125.
2006
-
17 beta-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men (vol 90, pg 6218, 2005).
91:1217-1217.
2006
-
Erratum: 17β-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men (Journal of Clinical Endocrinology and Metabolism (2005) 90 (6218-6229)).
91:1217.
2006
-
17β-Estradiol Supplementation Decreases Glucose Rate of Appearance and Disappearance with No Effect on Glycogen Utilization during Moderate Intensity Exercise in Men.
90:6218-6225.
2005
-
Estrogen Supplementation Reduces Whole Body Leucine and Carbohydrate Oxidation and Increases Lipid Oxidation in Men during Endurance Exercise.
90:3592-3599.
2005
-
Impact of Growth Hormone Supplementation on Adult Height in Turner Syndrome: Results of the Canadian Randomized Controlled Trial.
90:3360-3366.
2005
-
Impaired Activation of AMP-Kinase and Fatty Acid Oxidation by Globular Adiponectin in Cultured Human Skeletal Muscle of Obese Type 2 Diabetics.
90:3665-3672.
2005
-
Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy.
90:3215-3224.
2005
-
AMP-Activated Protein Kinase Is Not Down-Regulated in Human Skeletal Muscle of Obese Females.
89:4575-4580.
2004
-
A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer.
89:3668-3676.
2004
-
Alendronate in Primary Hyperparathyroidism: A Double-Blind, Randomized, Placebo-Controlled Trial.
89:3319-3325.
2004
-
The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma.
89:2859-2866.
2004
-
Patients on Appropriate T4Replacement Are as Content as They Would Be on Any Thyroid Hormone.
89:2507-2507.
2004
-
Authors’ Response: Dosage Recommendations for Combination Regimen of Thyroxine and 3,5,3′-Triiodothyronine.
89:1487-1487.
2004
-
Dosage Recommendations for Combination Regimen of Thyroxine and 3,5,3′-Triiodothyronine.
89:1486-1487.
2004
-
Does a Combination Regimen of Thyroxine (T4) and 3,5,3′-Triiodothyronine Improve Depressive Symptoms Better Than T4Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial.
88:4551-4555.
2003
-
A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines.
88:553-558.
2003
-
Expression of Prostaglandin I2Synthase, but Not Prostaglandin E Synthase, Changes in Myometrium of Women at Term Pregnancy.
87:5274-5282.
2002
-
A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis.
87:4528-4535.
2002
-
Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial.
87:3609-3617.
2002
-
Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial.
87:3609-3617.
2002
-
Differential Changes in 15-Hydroxyprostaglandin Dehydrogenase and Prostaglandin H Synthase (Types I and II) in Human Pregnant Myometrium.
87:1345-1352.
2002
-
Differential Changes in 15-Hydroxyprostaglandin Dehydrogenase and Prostaglandin H Synthase (Types I and II) in Human Pregnant Myometrium.
87:1345-1352.
2002
-
Dermopathy of Graves' Disease (Pretibial Myxedema): Long-Term Outcome.
87:438-446.
2002
-
Dermopathy of Graves’ Disease (Pretibial Myxedema): Long-Term Outcome.
87:438-446.
2002
-
Sudden Enlargement of Local Recurrent Thyroid Tumor after Recombinant Human TSH Administration.
86:5148-5151.
2001
-
Sudden Enlargement of Local Recurrent Thyroid Tumor after Recombinant Human TSH Administration.
86:5148-5151.
2001
-
Efficacy of Ultrasound-Guided Fine-Needle Aspiration Biopsy in the Diagnosis of Complex Thyroid Nodules.
86:4089-4091.
2001
-
Efficacy of Ultrasound-Guided Fine-Needle Aspiration Biopsy in the Diagnosis of Complex Thyroid Nodules.
86:4089-4091.
2001
-
Oral Cholecystographic Agents and the Thyroid.
86:1853-1860.
2001
-
Oral Cholecystographic Agents and the Thyroid.
86:1853-1860.
2001
-
Leptin Production and Release in the Dually in VitroPerfused Human Placenta.
85:4298-4301.
2000
-
Leptin Production and Release in the Duallyin VitroPerfused Human Placenta1.
85:4298-4301.
2000
-
Detection of Endocrine-Disrupting Chemicals in Samples of Second Trimester Human Amniotic Fluid.
85:2954-2957.
2000
-
Lack of Sex Difference in Cerebrospinal Fluid (CSF) Leptin Levels and Contribution of CSF/Plasma Ratios to Variations in Body Mass Index in Children.
84:3021-3024.
1999
-
Lack of Sex Difference in Cerebrospinal Fluid (CSF) Leptin Levels and Contribution of CSF/Plasma Ratios to Variations in Body Mass Index in Children.
84:3021-3024.
1999
-
Comparison of the Biochemical Responses to Human Parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in Healthy Humans.
84:2739-2743.
1999
-
Comparison of the Biochemical Responses to Human Parathyroid Hormone-(1–31)NH2and hPTH-(1–34) in Healthy Humans1.
84:2739-2743.
1999
-
Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group..
83:3169-3176.
1998
-
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)..
83:1976-1987.
1998
-
Cloning and Characterization of the Promoter Regions of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene: Analysis of Deoxyribonucleic Acid from Normal Subjects and Patients with Pseudohypoparathyroidism Type 1b.
82:1031-1040.
1997
-
A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid Hormone Versus Cyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis.
82:620-628.
1997
-
A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid HormoneVersusCyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis1.
82:620-628.
1997
-
Dimeric Inhibins in Amniotic Fluid, Maternal Serum, and Fetal Serum in Human Pregnancy.
82:218-222.
1997
-
Dimeric Inhibins in Amniotic Fluid, Maternal Serum, and Fetal Serum in Human Pregnancy1.
82:218-222.
1997
-
Late luteal phase dysphoric disorder and the thyroid axis revisited.
81:2280-2284.
1996
-
Late luteal phase dysphoric disorder and the thyroid axis revisited..
81:2280-2284.
1996
-
Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee.
81:1693-1696.
1996
-
2-[125I]iodomelatonin-binding sites in the human kidney and the effect of guanosine 5'-O-(3-thiotriphosphate)..
80:1560-1565.
1995
-
Melatonin receptors on human granulosa cell membranes.
80:1747-1749.
1995
-
Melatonin receptors on human granulosa cell membranes..
80:1747-1749.
1995
-
Concordant Graves' Disease after Bone Marrow Transplantation: Implications for Pathogenesis.
72:837-840.
1991
-
Inhibin and Estradiol Responses to Ovarian Hyperstimultion: Effects of Age and Predictive Value forin VitroFertilization Outcome.
70:358-364.
1990
-
Occult Ovarian Failure: A Syndrome of Infertility, Regular Menses, and Elevated Follicle-Stimulating Hormone Concentrations.
67:1190-1194.
1988
-
Changing Osteocalcin Concentrations During Pregnancy and Lactation: Implications for Maternal Mineral Metabolism*.
65:290-294.
1987
-
Separate Induction of MHC and Thyroid Microsomal Antigen (McAg) Expression on Thyroid Cell Monolayers: Enhancement of Lectin-Induced McAg Expression by Interferon-γ*.
64:1302-1308.
1987
-
Gonadotropin-Independent Precocious Puberty (“Testotoxicosis”): Influence of Maturational Status on Response to Ketoconazole.
64:328-333.
1987
-
Pharmacokinetic Characteristics of the Gonadotropin-Releasing Hormone Analog D-Ser(TBU)-6EA-10Luteinizing Hormone-Releasing Hormone (Buserelin) after Subcutaneous and Intranasal Administration in Children with Central Precocious Puberty.
63:1065-1070.
1986
-
Thyrocyte HLA-DR Expression and Interferon-γProduction in Autoimmune Thyroid Disease*.
63:695-708.
1986
-
Intranasal and Subcutaneous Treatment of Central Precocious Puberty in Both Sexes with a Long-Acting Analog of Luteinizing Hormone-Releasing Hormone*.
58:966-972.
1984
-
Characteristics of Antibody Produced During Chronic Treatment with LHRH.
44:784-790.
1977
-
EFFECT OF CARBIDOPA ON PROLACTIN, GROWTH HORMONE AND CORTISOL SECRETION IN MAN.
43:236-239.
1976
-
STIMULATION OF RHESUS MONKEY GH RELEASE: ARGININE VS PLASMA VOLUME EXPANSION1.
42:169-172.
1976
-
Effect of Clonidine on Growth Hormone, Prolactin, Luteinizing Hormone, Follicle-Stimulating Hormone, and Thyroid-Stimulating Hormone in the Serum of Normal Men.
41:827-832.
1975
-
Secondary drug failure occurring during chronic treatment with LHRH: appearance of an antibody..
41:640-643.
1975
-
THE SECRETION AND DISPOSITION OF CORTISOL DURING PREGNANCY*.
18:1076-1092.
1958
-
A CASE OF MASCULINIZING OVARIAN TUMOR: USE OF CORTICOSTEROID INHIBITION TEST IN DIAGNOSIS.
18:794-797.
1958
-
STUDIES ON THE ORIGIN OF ALDOSTERONE DURING HUMAN PREGNANCY*.
18:222-225.
1958
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)